Coronary Artery Bypass Graft Devices Market

The global coronary artery bypass graft devices market size is estimated to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing number of cardiovascular disorders and inclining geriatric population in the world.

Coronary artery bypass graft (CABG) is a form of heart surgery that treats patients suffering from coronary artery heart disease or severe angina. In case of coronary heart disease, a substance called plaque is formed in the coronary artery that performs the function of carrying oxygenated blood to the heart muscles. As the time passes, the plaque become hard that results in narrowing of the artery and reduces in flow of blood to the heart causing chest pain called angina. In coronary artery bypass graft, a healthy vein or artery from other portion of body is joined to jammed coronary artery that leads to the supply of oxygenated blood to the heart muscles.

There are some minimally invasive coronary artery bypass (MIDCAB) surgeries which are robotic-assisted surgery and endoscopic or thoracoscopic that help to ensure less bleeding, low risk of infection, smaller incision, and reduced recovery time. The commercial devices that are used for CABG include Ultima OPCAB system by Guidant, OPTrac STILLSITE Stabilizer, and OCTOPUS 2+ Tissue Stabilization System. With high number of heart patients, the market is anticipated to grow at a significant rate during the forecast period.

Market Trends, Drivers, Restraints, and Opportunities

• Increase in repetitive revascularization surgeries is a key driver to the market in the coming time period.
• Introduction of new techniques and use of minimal invasive methods are boosting the market growth in the near future.
• Unhealthy lifestyle and reduced psychical activities are causing rise in heart related issues, which requires CAGB surgeries. This is propelling the market to new heights.
• Inadequate reimbursement policies as well as complex payment models are restricting factors that can impede the market growth during the forecast period.
• High prevalence of cardiac diseases and advancement in the healthcare techniques as well as high research activities in the field are offering huge opportunities for the market during the projected period.

Scope of the Report

The report on the global coronary artery bypass graft devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Market Segment Insights

Off-pump CABG segment is expected to grow at a robust pace

Based on techniques, the global coronary artery bypass graft devices market is bifurcated into on-pump CABG and off-pump CABG. The off-pump CABG segment is anticipated to grow at a robust pace during the forecast period owing to rapid development of new technology with highly effective results of the technique. The OPCAB is used without the presences of heart-lung machines.

The on-pump CABG segment is also anticipated to grow at a considerable pace in the coming years attributed to the effective results and high number of cardiac patients. The techniques include the use of heart-lung machine or cardiopulmonary bypass machines.

Double CABG surgery segment is projected to expand at a considerable CAGR

On the basis of procedures, the market is divided into triple CABG surgery, single CABG surgery, double CABG surgery, quadruple CABG surgery, and others. The double CABG surgery segment is projected to expand at a considerable CAGR during the projected period owing to wide quantity of coronary arteries required in the CABG surgery. The requirement of the technique application is decided by the quantity of stenosis of a patient.

North America is anticipated to constitute a key market share

In terms of regions, the global coronary artery bypass graft devices market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key market share during the projected period owing to the well-developed healthcare facilities as well as presence of highly skilled professionals in the region. Furthermore, the significant rise in quality of research and high investment of the major players are pushing the regional market growth at a fast pace.

The Asia Pacific market, however, is estimated to register a considerable CAGR during the forecast period owing to the rise in per capita income among a large number of the population in the region as well as rapid development in the medical tourism industry in the region. The high population base is another key aspect for the regional market growth.

Segments

The global coronary artery bypass graft devices market has been segmented on the basis of

Techniques

• On-pump CABG
• Off-pump CABG

Procedures

• Single CABG Surgery
• Double CABG Surgery
• Triple CABG Surgery
• Quadruple CABG Surgery
• Others

Regions

• Asia Pacific
• North America
• Latin America
• Europe
• Middle East & Africa

Key Players

• Heratport
• Guidant
• Terumo
• Maquet
• Sorin Group
• Medtronic
• St. Jude Medicals
• Heartwave
• Edward Life sciences
• Boston Scientific
• Articure
• Teleflex Medicals
• Thoratec
• Biosense Webster

Competitive Landscape

The key market players in the global coronary artery bypass graft devices market are Heratport; Guidant; Terumo; Maquet; Sorin Group; Medtronic; St. Jude Medicals; Heartwave; Edward Life sciences; Boston Scientific; Articure; Teleflex Medicals; Thoratec; and Biosense Webster.